Literature DB >> 17972955

Proteasome inhibition therapies in childhood cancer.

F Zaman, B Fadeel, L Sävendahl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17972955     DOI： 10.1038/sj.leu.2404997

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

Review 1.  Humanin and age-related diseases: a new link?

Authors:  Zhenwei Gong; Emir Tas; Radhika Muzumdar
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-04       Impact factor: 5.555

2.  Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young mice.

Authors:  Emma Eriksson; Farasat Zaman; Dionisios Chrysis; Henrik Wehtje; Terhi J Heino; Lars Sävendahl
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

3.  Timing of proteasome inhibition as a pharmacologic strategy for prevention of muscle contractures in neonatal brachial plexus injury.

Authors:  Qingnian Goh; Sia Nikolaou; Kritton Shay-Winkler; Marianne E Emmert; Roger Cornwall
Journal:  FASEB J       Date:  2020-11-25       Impact factor: 5.834

4.  A unique amphiphilic triblock copolymer, nontoxic to human blood and potential supramolecular drug delivery system for dexamethasone.

Authors:  Irrum Mushtaq; Zareen Akhter; Muhammad Farooq; Farukh Jabeen; Ashfaq Ur Rehman; Sadia Rehman; Sidra Ayub; Bushra Mirza; Muhammad Siddiq; Farasat Zaman
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.